Heart Disease Trial, Recruiting NCT02820233 Sponsor: Douglas B. Sawyer Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT02820233
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with severe coronary artery disease and are scheduled to have coronary artery bypass surgery (a heart operation to improve blood flow).

Who may not be able to join:

  • People who are under 18 years of age.
  • People who are unwilling or unable to give their informed consent to participate.
  • People with a known active inflammation of the heart muscle (myocarditis).
  • People with a condition where the heart muscle is abnormally thick (hypertrophic cardiomyopathy).
  • People with scarring or stiffening around the heart (constrictive pericarditis) or other significant disease affecting the sac surrounding the heart.
  • People with severely high blood pressure in the lungs (severe pulmonary hypertension).
  • People with significantly reduced kidney function, as measured by a specific blood test result (confirm with trial site).
  • People with severe irregular or abnormal heart rhythms originating from the lower chambers of the heart (severe ventricular arrhythmias).
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Douglas B. Sawyer
Registry
ClinicalTrials.gov
Start date
1 June 2015
Est. completion
1 September 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The number of highly proliferative clones isolated

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov